The World Health Organization (WHO) has reported the emergence of a new Covid-19 mutation called Stratus (previously identified as Xfg), which is rapidly spreading across several European countries, replacing the Nimbus variant. This new variant has shown a greater ability to evade antibodies.
Originally detected in India during the spring season, one of the most notable symptoms of Stratus is a hoarse voice. Unlike previous variants where loss of smell and taste were common signs, patients infected with Stratus mainly report sore throat, dry cough, and hoarseness.
In the United Kingdom, infected individuals are experiencing severe throat pain and difficulty swallowing, along with other symptoms such as fever, fatigue, muscle aches, and respiratory congestion.
Data shows that the proportion of cases caused by the Stratus variant in Europe has increased from 10.6% to 16.7%, while in Southeast Asia this variant now accounts for 68.7% of cases. WHO is calling for special measures to address the uncertainties around the impact and spread of this mutation.
The spread of the Stratus variant highlights the ongoing evolution of Covid-19, posing continuous challenges to global health systems. The distinctive symptom of hoarseness may assist in earlier detection and quicker isolation of cases.
The increasing prevalence of Stratus in Europe and Southeast Asia suggests it has a transmissibility advantage over previous variants. This necessitates revisiting vaccination and treatment strategies, including the development of vaccines tailored to new variants.
WHO emphasizes the importance of continued monitoring, transparent reporting, and public communication to prevent panic and raise awareness of new symptoms.
This situation underlines the need for widespread vaccination, adherence to protective measures, and international cooperation in the ongoing fight against the pandemic, as new mutations can alter the virus’s transmission dynamics.
Source: Gazeta Demos